Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for BLFS

Stock Name	BioLife Solutions Inc
Ticker	BLFS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US09062W2044
LEI	549300G2IVCMC2TJDW72

Show aggregate BLFS holdings

News associated with BLFS

TD Asset Management Inc Takes Position in BioLife Solutions, Inc. (NASDAQ:BLFS): TD Asset Management Inc acquired a new stake in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 38,820 shares of the medical equipment provider’s stock, valued at approximately $887,000. Other hedge funds and other institutional […] - 2025-08-05 04:36:51
Peek Under The Hood: SPSM Has 16% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-25 08:59:23
Cerity Partners LLC Boosts Stake in BioLife Solutions, Inc. (NASDAQ:BLFS): Cerity Partners LLC grew its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 22.8% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 48,603 shares of the medical equipment provider’s stock after buying an additional 9,015 shares during the period. Cerity Partners LLC’s holdings in BioLife Solutions were worth $1,110,000 […] - 2025-07-23 04:56:57
Louisiana State Employees Retirement System Cuts Stake in BioLife Solutions, Inc. (NASDAQ:BLFS): Louisiana State Employees Retirement System lessened its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 2.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,000 shares of the medical equipment provider’s stock after selling 500 shares during […] - 2025-07-22 07:13:07
New York State Common Retirement Fund Has $6.79 Million Stock Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS): New York State Common Retirement Fund lifted its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 14.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 297,448 shares of the medical equipment provider’s stock after acquiring an additional […] - 2025-07-21 04:37:06
New York State Teachers Retirement System Sells 2,907 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS): New York State Teachers Retirement System decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 4.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 57,569 shares of the medical equipment provider’s stock after selling 2,907 shares during the period. New York […] - 2025-07-10 05:32:55
Allspring Global Investments Holdings LLC Sells 1,313 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS): Allspring Global Investments Holdings LLC trimmed its position in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 1.4% in the first quarter, HoldingsChannel reports. The firm owned 94,019 shares of the medical equipment provider’s stock after selling 1,313 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in BioLife Solutions were worth $2,147,000 as […] - 2025-07-08 04:37:00
Calamos Advisors LLC Sells 8,169 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS): Calamos Advisors LLC trimmed its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 24.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 24,852 shares of the medical equipment provider’s stock after selling 8,169 shares during the period. Calamos Advisors LLC owned […] - 2025-07-07 06:00:48
BioLife Solutions (NASDAQ:BLFS) vs. ResMed (NYSE:RMD) Critical Review: BioLife Solutions (NASDAQ:BLFS – Get Free Report) and ResMed (NYSE:RMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability and earnings. Insider and Institutional Ownership 93.2% of BioLife Solutions shares […] - 2025-07-07 03:17:01
Analysts Set BioLife Solutions, Inc. (NASDAQ:BLFS) Price Target at $31.17: Shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six brokerages that are presently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have issued ratings on […] - 2025-06-20 02:36:49
BioLife Solutions, Inc. (NASDAQ:BLFS) Stake Lifted by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.: MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 5.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 20,508 shares of the medical equipment provider’s stock after buying an additional 1,047 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings […] - 2025-05-29 04:36:51
BioLife Solutions, Inc. (NASDAQ:BLFS) Stake Lessened by BNP Paribas Financial Markets: BNP Paribas Financial Markets cut its stake in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 32.8% during the 4th quarter, HoldingsChannel reports. The fund owned 14,010 shares of the medical equipment provider’s stock after selling 6,835 shares during the period. BNP Paribas Financial Markets’ holdings in BioLife Solutions were worth $364,000 as of its […] - 2025-05-27 04:31:01
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Rating of “Buy” by Analysts: Shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) have earned a consensus recommendation of “Buy” from the six ratings firms that are covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have issued a report on […] - 2025-05-23 02:22:48
BioLife Solutions (NASDAQ:BLFS) Downgraded by StockNews.com to Sell: StockNews.com lowered shares of BioLife Solutions (NASDAQ:BLFS – Free Report) from a hold rating to a sell rating in a research note published on Wednesday morning. Separately, HC Wainwright reaffirmed a “buy” rating and set a $30.00 price objective on shares of BioLife Solutions in a research note on Tuesday, May 13th. One research analyst […] - 2025-05-22 06:10:52
BioLife Solutions, Inc. (NASDAQ:BLFS) Stake Lowered by Ameriprise Financial Inc.: Ameriprise Financial Inc. cut its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 839,105 shares of the medical equipment provider’s stock after selling 4,123 shares during the quarter. Ameriprise […] - 2025-05-15 05:22:55
BioLife Solutions (NASDAQ:BLFS) Raised to “Hold” at StockNews.com: BioLife Solutions (NASDAQ:BLFS – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. Separately, HC Wainwright reiterated a “buy” rating and issued a $30.00 price objective on shares of BioLife Solutions in a report on […] - 2025-05-15 02:32:53
Stifel Financial Corp Has $441,000 Stock Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS): Stifel Financial Corp increased its position in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 30.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,994 shares of the medical equipment provider’s stock after purchasing an additional 4,006 shares during the quarter. Stifel Financial […] - 2025-05-13 04:50:57
Dimensional Fund Advisors LP Purchases 40,416 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS): Dimensional Fund Advisors LP grew its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 4.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 887,008 shares of the medical equipment provider’s stock after purchasing an additional 40,416 shares during the quarter. Dimensional Fund […] - 2025-05-07 05:22:55
BioLife Solutions, Inc. (NASDAQ:BLFS) Receives $31.17 Average PT from Analysts: BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued ratings on the stock in the last […] - 2025-05-01 03:06:50
Envestnet Asset Management Inc. Has $5.16 Million Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS): Envestnet Asset Management Inc. lifted its stake in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 18.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 198,695 shares of the medical equipment provider’s stock after acquiring an additional 31,167 shares […] - 2025-04-23 04:38:47
StockNews.com Downgrades BioLife Solutions (NASDAQ:BLFS) to Sell: BioLife Solutions (NASDAQ:BLFS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Monday. Other research analysts also recently issued reports about the stock. Benchmark reiterated a “buy” rating and set a $30.00 price objective on shares of BioLife Solutions in […] - 2025-04-02 02:20:53
Analysts Anticipate SPTM Will Reach $83: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-19 08:56:30
Brokerages Set BioLife Solutions, Inc. (NASDAQ:BLFS) PT at $29.86: BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have issued a report on the stock […] - 2025-03-12 04:10:56
5 Low-Leverage Stocks to Buy Amid Volatile Market Sentiment: The crux of safe investment lies in choosing a company that is not burdened with debt. You may buy BLFS, BHLB, NVDA, GBX and EZPW. - 2025-03-10 11:58:00
Oppenheimer Asset Management Inc. Sells 9,146 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS): Oppenheimer Asset Management Inc. trimmed its position in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 35.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,763 shares of the medical equipment provider’s stock after selling 9,146 shares during the quarter. Oppenheimer Asset Management […] - 2025-03-06 09:05:09
Contrasting BioLife Solutions (NASDAQ:BLFS) and Vivani Medical (NASDAQ:VANI): Vivani Medical (NASDAQ:VANI – Get Free Report) and BioLife Solutions (NASDAQ:BLFS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Volatility & Risk Vivani Medical has a […] - 2025-02-28 05:12:50
New York State Common Retirement Fund Acquires 10,836 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS): New York State Common Retirement Fund grew its position in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 4.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 260,315 shares of the medical equipment provider’s stock after purchasing an additional 10,836 shares during the period. New […] - 2025-02-27 06:51:01
Analysts Forecast 12% Upside For SPTM: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-06 10:49:33
BioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Up 5.8% in January: BioLife Solutions, Inc. (NASDAQ:BLFS – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 3,310,000 shares, a growth of 5.8% from the December 31st total of 3,130,000 shares. Based on an average trading volume of 379,000 shares, the days-to-cover ratio […] - 2025-02-05 05:04:47

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc BLFS holdings

Date	Number of BLFS Shares Held	Base Market Value of BLFS Shares	Local Market Value of BLFS Shares	Change in BLFS Shares Held	Change in BLFS Base Value	Current Price per BLFS Share Held	Previous Price per BLFS Share Held
2025-09-26 (Friday)	30,604	USD 755,919	USD 755,919
2025-09-25 (Thursday)	30,604	USD 740,005	USD 740,005	0	USD 2,143	USD 24.18	USD 24.11
2025-09-24 (Wednesday)	30,604	USD 737,862	USD 737,862
2025-09-17 (Wednesday)	30,406	USD 777,938	USD 777,938	0	USD -12,010	USD 25.585	USD 25.98
2025-09-16 (Tuesday)	30,406	USD 789,948	USD 789,948
2025-09-12 (Friday)	30,208	USD 770,606	USD 770,606
2025-09-11 (Thursday)	30,208	USD 807,762	USD 807,762	396	USD 26,091	USD 26.74	USD 26.22

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BLFS by Blackrock for IE00B3VWM098

Show aggregate share trades of BLFS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 396 26.740* 24.06
2025-08-21 SELL -22 25.080* 24.06 Profit of 529 on sale
2025-07-31 BUY 66 21.260* 24.07
2025-06-30 SELL -44 21.540* 24.35 Profit of 1,071 on sale
2025-06-25 SELL -22 21.370* 24.41 Profit of 537 on sale
2025-06-20 SELL -44 21.220* 24.48 Profit of 1,077 on sale
2025-05-23 BUY 22 21.780* 24.84
2025-05-19 SELL -22 22.940* 24.92 Profit of 548 on sale
2025-05-15 SELL -66 21.990* 24.96 Profit of 1,647 on sale
2025-05-12 SELL -22 23.890* 25.01 Profit of 550 on sale
2025-05-09 SELL -22 23.290* 25.03 Profit of 551 on sale
2025-04-30 SELL -22 24.110* 25.14 Profit of 553 on sale
2025-04-24 SELL -44 24.800* 25.16 Profit of 1,107 on sale
2025-04-17 SELL -22 21.910* 25.31 Profit of 557 on sale
2025-04-15 SELL -66 22.430* 25.38 Profit of 1,675 on sale
2025-04-14 SELL -66 22.080* 25.41 Profit of 1,677 on sale
2025-04-09 SELL -88 22.790* 25.53 Profit of 2,247 on sale
2025-04-07 SELL -154 21.940* 25.63 Profit of 3,947 on sale
2025-04-04 SELL -220 20.880* 25.69 Profit of 5,651 on sale
2025-03-31 BUY 22 22.840* 25.78
2025-03-19 SELL -44 25.480* 25.79 Profit of 1,135 on sale
2025-03-14 SELL -132 25.000* 25.81 Profit of 3,407 on sale
2025-03-13 SELL -44 25.060* 25.82 Profit of 1,136 on sale
2025-03-12 SELL -748 26.270* 25.81 Profit of 19,307 on sale
2025-03-07 SELL -44 25.830* 25.81 Profit of 1,136 on sale
2025-03-06 SELL -66 26.800* 25.80 Profit of 1,703 on sale
2025-03-03 SELL -22 24.510* 25.83 Profit of 568 on sale
2025-02-28 SELL -132 24.000* 25.86 Profit of 3,413 on sale
2025-02-26 SELL -22 25.160* 25.91 Profit of 570 on sale
2025-02-25 SELL -66 25.130* 25.92 Profit of 1,711 on sale
2025-02-18 BUY 110 28.320* 25.80
2025-02-13 BUY 22 27.140* 25.69
2025-02-12 BUY 22 26.340* 25.68
2025-02-11 BUY 66 26.870* 25.65
2025-02-06 BUY 198 26.190* 25.63
2025-01-27 BUY 22 28.280* 25.23
2024-12-30 BUY 110 26.270* 25.01
2024-12-06 BUY 88 26.240* 24.89
2024-12-05 BUY 22 25.180* 24.88
2024-12-04 BUY 110 26.380* 24.82
2024-11-29 BUY 110 27.470* 24.54
2024-11-27 BUY 88 27.160* 24.31
2024-11-26 BUY 22 27.060* 24.19
2024-11-21 BUY 110 25.390* 23.89
2024-11-20 BUY 66 25.010* 23.83
2024-11-18 BUY 264 20.470* 24.13
2024-11-12 BUY 176 26.500* 23.97
2024-11-08 BUY 110 26.130* 23.81
2024-11-07 BUY 330 26.140* 23.64
2024-11-06 BUY 44 26.600* 23.39
2024-10-31 BUY 22 23.400* 22.71
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	396	26.740*	24.06
2025-08-21	SELL	-22	25.080*	24.06 Profit of 529 on sale
2025-07-31	BUY	66	21.260*	24.07
2025-06-30	SELL	-44	21.540*	24.35 Profit of 1,071 on sale
2025-06-25	SELL	-22	21.370*	24.41 Profit of 537 on sale
2025-06-20	SELL	-44	21.220*	24.48 Profit of 1,077 on sale
2025-05-23	BUY	22	21.780*	24.84
2025-05-19	SELL	-22	22.940*	24.92 Profit of 548 on sale
2025-05-15	SELL	-66	21.990*	24.96 Profit of 1,647 on sale
2025-05-12	SELL	-22	23.890*	25.01 Profit of 550 on sale
2025-05-09	SELL	-22	23.290*	25.03 Profit of 551 on sale
2025-04-30	SELL	-22	24.110*	25.14 Profit of 553 on sale
2025-04-24	SELL	-44	24.800*	25.16 Profit of 1,107 on sale
2025-04-17	SELL	-22	21.910*	25.31 Profit of 557 on sale
2025-04-15	SELL	-66	22.430*	25.38 Profit of 1,675 on sale
2025-04-14	SELL	-66	22.080*	25.41 Profit of 1,677 on sale
2025-04-09	SELL	-88	22.790*	25.53 Profit of 2,247 on sale
2025-04-07	SELL	-154	21.940*	25.63 Profit of 3,947 on sale
2025-04-04	SELL	-220	20.880*	25.69 Profit of 5,651 on sale
2025-03-31	BUY	22	22.840*	25.78
2025-03-19	SELL	-44	25.480*	25.79 Profit of 1,135 on sale
2025-03-14	SELL	-132	25.000*	25.81 Profit of 3,407 on sale
2025-03-13	SELL	-44	25.060*	25.82 Profit of 1,136 on sale
2025-03-12	SELL	-748	26.270*	25.81 Profit of 19,307 on sale
2025-03-07	SELL	-44	25.830*	25.81 Profit of 1,136 on sale
2025-03-06	SELL	-66	26.800*	25.80 Profit of 1,703 on sale
2025-03-03	SELL	-22	24.510*	25.83 Profit of 568 on sale
2025-02-28	SELL	-132	24.000*	25.86 Profit of 3,413 on sale
2025-02-26	SELL	-22	25.160*	25.91 Profit of 570 on sale
2025-02-25	SELL	-66	25.130*	25.92 Profit of 1,711 on sale
2025-02-18	BUY	110	28.320*	25.80
2025-02-13	BUY	22	27.140*	25.69
2025-02-12	BUY	22	26.340*	25.68
2025-02-11	BUY	66	26.870*	25.65
2025-02-06	BUY	198	26.190*	25.63
2025-01-27	BUY	22	28.280*	25.23
2024-12-30	BUY	110	26.270*	25.01
2024-12-06	BUY	88	26.240*	24.89
2024-12-05	BUY	22	25.180*	24.88
2024-12-04	BUY	110	26.380*	24.82
2024-11-29	BUY	110	27.470*	24.54
2024-11-27	BUY	88	27.160*	24.31
2024-11-26	BUY	22	27.060*	24.19
2024-11-21	BUY	110	25.390*	23.89
2024-11-20	BUY	66	25.010*	23.83
2024-11-18	BUY	264	20.470*	24.13
2024-11-12	BUY	176	26.500*	23.97
2024-11-08	BUY	110	26.130*	23.81
2024-11-07	BUY	330	26.140*	23.64
2024-11-06	BUY	44	26.600*	23.39
2024-10-31	BUY	22	23.400*	22.71

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BLFS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	26,787	0	74,267	36.1%
2025-09-18	29,283	0	139,438	21.0%
2025-09-17	32,668	0	109,447	29.8%
2025-09-16	24,267	0	83,907	28.9%
2025-09-15	47,455	0	167,026	28.4%
2025-09-12	64,717	0	233,920	27.7%
2025-09-11	63,966	0	212,200	30.1%
2025-09-10	85,160	0	128,016	66.5%
2025-09-09	40,410	0	84,332	47.9%
2025-09-08	44,615	0	95,423	46.8%
2025-09-05	41,657	0	91,545	45.5%
2025-09-04	80,984	0	148,754	54.4%
2025-09-03	100,223	0	158,677	63.2%
2025-09-02	107,618	0	177,228	60.7%
2025-08-29	47,949	0	123,647	38.8%
2025-08-28	78,122	0	284,719	27.4%
2025-08-27	50,386	0	87,094	57.9%
2025-08-26	56,959	2,163	127,654	44.6%
2025-08-25	95,500	0	173,252	55.1%
2025-08-22	85,276	0	251,845	33.9%
2025-08-21	46,358	0	176,748	26.2%
2025-08-20	55,507	0	209,146	26.5%
2025-08-19	56,126	0	154,157	36.4%
2025-08-18	64,836	0	194,173	33.4%
2025-08-15	82,608	0	761,868	10.8%
2025-08-14	83,101	0	190,260	43.7%
2025-08-13	89,466	0	244,422	36.6%
2025-08-12	62,856	0	225,961	27.8%
2025-08-11	249,272	0	860,675	29.0%
2025-08-08	230,905	177	308,162	74.9%
2025-08-07	119,344	0	142,525	83.7%
2025-08-06	209,701	0	286,220	73.3%
2025-08-05	103,929	0	150,877	68.9%
2025-08-04	89,461	0	113,789	78.6%
2025-08-01	104,227	0	141,515	73.7%
2025-07-31	75,040	0	110,841	67.7%
2025-07-30	70,065	0	112,270	62.4%
2025-07-29	51,371	0	87,322	58.8%
2025-07-28	58,200	0	121,876	47.8%
2025-07-25	88,211	58	122,196	72.2%
2025-07-24	79,321	0	149,611	53.0%
2025-07-23	91,633	0	170,517	53.7%
2025-07-22	154,725	1,290	443,858	34.9%
2025-07-21	127,027	1,297	227,836	55.8%
2025-07-18	77,426	0	135,696	57.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE